BNP Paribas Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$267M Sell
4,407,916
-58,912
-1% -$3.43M 0.31% 60
2025
Q4
$241M Buy
4,466,828
+2,453,620
+122% +$118M 0.28% 65
2025
Q3
$90.3M Sell
2,013,208
-149,707
-7% -$6.99M 0.23% 97
2025
Q2
$100M Buy
2,162,915
+18,575
+0.9% +$912K 0.24% 92
2025
Q1
$131M Buy
2,144,340
+212,371
+11% +$12.4M 0.35% 62
2024
Q4
$109M Buy
1,931,969
+947,723
+96% +$53M 0.27% 87
2024
Q3
$50.9M Sell
984,246
-147,048
-13% -$6.9M 0.13% 171
2024
Q2
$47M Sell
1,131,294
-1,140,241
-50% -$51M 0.12% 179
2024
Q1
$123M Sell
2,271,535
-171,481
-7% -$8.74M 0.33% 63
2023
Q4
$125M Sell
2,443,016
-1,096,427
-31% -$57.6M 0.35% 65
2023
Q3
$205M Sell
3,539,443
-543,558
-13% -$33.3M 0.63% 26
2023
Q2
$261M Sell
4,083,001
-184,831
-4% -$12.4M 0.81% 16
2023
Q1
$296M Buy
4,267,832
+185,493
+5% +$13.1M 1.03% 14
2022
Q4
$294M Buy
4,082,339
+341,987
+9% +$25.8M 1.05% 9
2022
Q3
$266M Buy
3,740,352
+757,184
+25% +$54.9M 1.05% 10
2022
Q2
$230M Sell
2,983,168
-213,064
-7% -$16.2M 0.88% 17
2022
Q1
$233M Sell
3,196,232
-105,150
-3% -$7.06M 0.81% 21
2021
Q4
$206M Buy
3,301,382
+561,560
+20% +$32.9M 0.69% 25
2021
Q3
$162M Buy
2,739,822
+50,937
+2% +$3.35M 0.6% 30
2021
Q2
$178M Buy
2,688,885
+71,681
+3% +$4.67M 0.64% 27
2021
Q1
$165M Buy
2,617,204
+29,849
+1% +$1.86M 0.68% 26
2020
Q4
$160M Buy
2,587,355
+195,718
+8% +$12M 0.74% 22
2020
Q3
$143M Buy
2,391,637
+407,394
+21% +$24.5M 0.81% 18
2020
Q2
$117M Buy
1,984,243
+116,797
+6% +$6.99M 0.79% 18
2020
Q1
$104M Sell
1,867,446
-223,161
-11% -$13.6M 0.89% 13
2019
Q4
$134M Sell
2,090,607
-199,153
-9% -$11.4M 0.92% 12
2019
Q3
$116M Buy
2,289,760
+115,177
+5% +$5.41M 0.89% 12
2019
Q2
$98.6M Buy
2,174,583
+290,181
+15% +$13.5M 0.81% 13
2019
Q1
$89.9M Buy
1,884,402
+669,173
+55% +$33.3M 0.75% 13
2018
Q4
$61.9M Sell
1,215,229
-287,122
-19% -$15.4M 0.57% 25
2018
Q3
$93.3M Buy
1,502,351
+167,198
+13% +$9.92M 0.72% 15
2018
Q2
$73.9M Buy
1,335,153
+451,401
+51% +$24.4M 0.62% 20
2018
Q1
$55.9M Buy
883,752
+164,254
+23% +$10.6M 0.47% 31
2017
Q4
$44.1M Sell
719,498
-481,727
-40% -$30.1M 0.38% 49
2017
Q3
$76.6M Buy
1,201,225
+489,404
+69% +$28.6M 0.65% 23
2017
Q2
$39.7M Buy
711,821
+565,954
+388% +$30.8M 0.35% 62
2017
Q1
$7.93M Sell
145,867
-115,541
-44% -$6.34M 0.07% 364
2016
Q4
$15.3M Sell
261,408
-89,103
-25% -$4.87M 0.15% 181
2016
Q3
$18.9M Sell
350,511
-218,701
-38% -$14M 0.16% 155
2016
Q2
$41.9M Sell
569,212
-405,162
-42% -$28.6M 0.35% 67
2016
Q1
$62.2M Buy
974,374
+83,095
+9% +$5.24M 0.53% 34
2015
Q4
$61.3M Sell
891,279
-74,343
-8% -$4.91M 0.52% 40
2015
Q3
$57.2M Sell
965,622
-166,745
-15% -$10.6M 0.5% 35
2015
Q2
$75.3M Sell
1,132,367
-8,093
-0.7% -$533K 0.61% 22
2015
Q1
$73.6M Buy
1,140,460
+518,173
+83% +$32.4M 0.56% 27
2014
Q4
$36.7M Sell
622,287
-41,353
-6% -$2.33M 0.3% 106
2014
Q3
$34M Buy
663,640
+37,289
+6% +$1.86M 0.28% 110
2014
Q2
$30.4M Sell
626,351
-1,161,865
-65% -$57.3M 0.24% 126
2014
Q1
$92.9M Sell
1,788,216
-209,789
-10% -$11.2M 0.7% 20
2013
Q4
$106M Buy
1,998,005
+278,871
+16% +$14.2M 0.79% 16
2013
Q3
$79.6M Buy
1,719,134
+1,434,598
+504% +$63M 0.6% 38
2013
Q2
$12.7M Buy
+284,536
New +$12.4M 0.09% 255

Other funds holding BMY

BNP Paribas Asset Management's BMY Position: Q1 2026 in Review

BNP Paribas Asset Management reduced its Bristol-Myers Squibb (BMY) stake by 1.3% in Q1 2026, selling an estimated $3.43M and leaving 4,407,916 shares worth $267M. The position accounts for 0.31% of the portfolio, ranked #60.

BNP Paribas Asset Management first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $296M in Q1 2023. 2,518 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • BNP Paribas Asset Management held 4,407,916 shares of Bristol-Myers Squibb worth $267M as of Q1 2026.
  • BNP Paribas Asset Management sold 58,912 Bristol-Myers Squibb shares in Q1 2026, an estimated $3.43M.
  • Bristol-Myers Squibb made up 0.31% of BNP Paribas Asset Management's portfolio in Q1 2026, its #60 holding.
  • BNP Paribas Asset Management first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
  • BNP Paribas Asset Management's Bristol-Myers Squibb position peaked at $296M in Q1 2023.
  • 2,518 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on BNP Paribas Asset Management's 13F filing for Q1 2026, filed 14 May 2026.